Perception of side effects of oncological systemic therapy in patients with breast and gynecological cancers

• Conditions: C56; C50; Malignant neoplasm of ovary; Malignant neoplasm of breast

• Registration Number: DRKS00017766
• Lead Sponsor: Kliniken Essen Mitte

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2018-05-23
• Study Start: 2019-08-05
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 150

Inclusion Criteria

Age >18 years
Initial chemotherapy treatment at the Department of Gynecology & Gynecologic Oncology of the Essen-Mitte Hospital for senological or gynecological tumors
Willingness to participate in the study + signed consent form

Exclusion Criteria

Lack of German understanding
Reading difficulties / illiteracy
expected life duration of therapy <3 months

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
This prospective study aims to investigate how side effects of systemic therapy of patients with gynecologic malignancies are perceived and assessed / categorized in their significance.

Secondary Outcome Measures

Name	Time	Method
Evaluation of perception of side effects and their importance in patients undergoing maintenance therapy<br>• Evaluation of perception of side effects at different times of treatment